[迪特尔类类化合物的化学和生物活性]
1Faculty of Pharmaceutical Sciences, Hokkaido University of Science.
来自Aconitum和Delphinium植物的迪特尔类类化合物显示出作为抗瘤剂的潜力. 合成衍生物表现出显著的细胞毒性活性,特别是对抗药物耐药的癌细胞,提供了新的治疗途径.
科学领域:
- 植物化学 植物化学
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 迪特类类化合物是Aconitum和Delphinium植物中发现的关键生物活性化合物.
- 阿科尼丁类类化合物对中枢神经系统具有高度毒性,而柳科克类和C20-diterpenoid类类化合物对中枢神经系统具有较低的毒性.
- 以前的研究表明,一些迪特尔类类化合物对各种人类瘤细胞系具有轻微的细胞毒性活性.
研究的目的:
- 为了研究特定的C19和C20-diterpenoid类化合物的合成衍生物的细胞毒性潜力.
- 确定具有针对药物敏感和多药耐药 (MDR) 癌细胞的新型抗瘤剂.
- 探索非细胞毒性类似物对MDR细胞对常规化疗敏感化的能力.
主要方法:
- 来自Aconitum和Delphinium物种的迪特尔化的植物化学研究和结构阐明.
- 基于德尔科辛,德尔菲林,卢西杜斯库林,伪科布辛和科布辛的新衍生物的合成.
- 在体外细胞毒性测定对人类瘤细胞系的小组,包括MDR亚系 (例如,KB-VIN).
主要成果:
- 几种合成二甲类化物衍生物对测试的人类瘤细胞系表现出显著的细胞毒性活性.
- 某些衍生物与其对药物敏感的对应物相比,对抗多药耐药 (MDR) 癌细胞具有更强的效力.
- 非细胞毒性莱科克托尼类型类衍生物有效地使MDR细胞对帕克利塔克塞尔,温克里斯和多克索鲁比辛敏感.
结论:
- 合成二甲类类化合物代表了开发新型抗癌疗法的有希望的候选人.
- 这些化合物显示出克服癌症多药耐药性的潜力.
- 对这些衍生物的进一步研究可能会导致癌症治疗的新策略.
更多相关视频
07:59A Customizable Approach for the Enzymatic Production and Purification of Diterpenoid Natural Products
Published on: October 4, 2019
11:44Cellular Membrane Affinity Chromatography Columns to Identify Specialized Plant Metabolites Interacting with Immobilized Tropomyosin Kinase Receptor B
Published on: January 19, 2022
相关概念视频
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Direct-Acting Cholinergic Agonists: Pharmacokinetics
